» Articles » PMID: 34522911

Vaccination Reduces Need for Emergency Care in Breakthrough COVID-19 Infections: A Multicenter Cohort Study

Overview
Date 2021 Sep 15
PMID 34522911
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Background: While recent literature has shown the efficacy of the SARS-CoV-2 vaccine in preventing infection, it's impact on need for emergency care/hospitalization in breakthrough infections remain unclear, particularly in regions with a high rate of variant viral strains. We aimed to determine if vaccination reduces hospital visits in breakthrough COVID-19.

Methods: This observational cohort analysis compared unvaccinated (UV), partially vaccinated (PV), and fully vaccinated (FV) adult patients with SARS-CoV-2 infection requiring emergency care(EC)/hospitalization within an eight-hospital system in Michigan. Demographic and clinical variables were obtained from the electronic record. Vaccination data was obtained from the Michigan Care Improvement Registry and Centers for Disease Control vaccine tracker. Primary endpoint was rate of emergency care/hospitalization encounters among patients diagnosed with COVID-19. Secondary outcome was severe disease-composite outcome (ICU, mechanical ventilation, or in-hospital death).

Findings: Between December 15,2020 and April 30,2021, 11,834 EC encounters were included:10,880 (91.9%) UV, 825 (7%) PV, 129 (1.1%) FV. Average age was 53.0 ± 18.2 and 52.8% were female. Accounting for the SARS-CoV-2 vaccination population groups in Michigan, the ED encounters/hospitalizations rate relevant to COVID-19 was 96% lower in FV versus UV (multiplicative effect:0.04, 95% CI 0.03 to 0.06, p < 0.001) in negative binomial regression. COVID-19 EC visits rate peaked at 22.61, 12.88, and 1.29 visits per 100000 for the UV, PV, and FV groups, respectively. In the propensity-score matching weights analysis, FV had a lower risk of composite disease compared to UV but statistically insignificant (HR 0.84, 95% CI 0.52 to 1.38).

Interpretation: The need for emergency care/hospitalization due to breakthrough COVID-19 is an exceedingly rare event in fully vaccinated patients. As vaccination has increased regionally, EC visits amongst fully vaccinated individuals have remained low and occur much less frequently than unvaccinated individuals. If hospital-based treatment is required, elderly patients with significant comorbidities are at high-risk for severe outcomes regardless of vaccination status.

Citing Articles

A Cross-Sectional Study of Attitude and Behaviour of Individuals Towards Visiting the Hospital During the COVID-19 Pandemic in India.

Shamsundar M, Choudhary S Brown J Hosp Med. 2025; 1(2):36121.

PMID: 40046288 PMC: 11878854. DOI: 10.56305/001c.36121.


Comparative analysis of clinical characteristics of COVID-19 among vaccinated and unvaccinated patients in a major treatment facility in Ghana.

Calys-Tagoe B, Oliver-Commey J, Ghartey G, Mohammed A, Bandoh D, Owoo C Ghana Med J. 2024; 57(4):293-299.

PMID: 38957848 PMC: 11215220. DOI: 10.4314/gmj.v57i4.6.


Immune cell populations and induced immune responses at admission in patients hospitalized with vaccine breakthrough SARS-CoV-2 infections.

Sejdic A, Hartling H, Gitz Holler J, Gjaerde L, Lindegaard B, Matovu Dungu A Front Immunol. 2024; 15:1360843.

PMID: 38903511 PMC: 11188326. DOI: 10.3389/fimmu.2024.1360843.


Cardioprotective effects of vaccination in hospitalized patients with COVID-19.

Madrid J, Agarwal P, Muller-Peltzer K, Benning L, Selig M, Rolauffs B Clin Exp Med. 2024; 24(1):103.

PMID: 38758248 PMC: 11101587. DOI: 10.1007/s10238-024-01367-3.


Development and evaluation of a Lateral flow immunoassay (LFIA) prototype for the detection of IgG anti-SARS-CoV-2 antibodies.

Fogaca M, Saavedra D, Lopes-Luz L, Ribeiro B, da Silva Pinto L, Nagata T Heliyon. 2024; 10(9):e29938.

PMID: 38707409 PMC: 11066624. DOI: 10.1016/j.heliyon.2024.e29938.


References
1.
Lurie N, Saville M, Hatchett R, Halton J . Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med. 2020; 382(21):1969-1973. DOI: 10.1056/NEJMp2005630. View

2.
Piroth L, Cottenet J, Mariet A, Bonniaud P, Blot M, Tubert-Bitter P . Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2020; 9(3):251-259. PMC: 7832247. DOI: 10.1016/S2213-2600(20)30527-0. View

3.
van Walraven C, Austin P, Jennings A, Quan H, Forster A . A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009; 47(6):626-33. DOI: 10.1097/MLR.0b013e31819432e5. View

4.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

5.
Shen X, Tang H, Pajon R, Smith G, Glenn G, Shi W . Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351. N Engl J Med. 2021; 384(24):2352-2354. PMC: 8063884. DOI: 10.1056/NEJMc2103740. View